SCHEMBL29686589

SCHEMBL29686589

[2H]C([2H])([2H])Oc1c(Nc2cc(Nc3cc(C)nc(C)n3)ncc2C(=O)NOCC)cc(F)cc1-c1cnc(C)cn1

nearest known ligand 0.43

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 20/20 0.43
▸ JAK1 P23458 15/20 0.43
▸ CYP2C19 P33261 1/20 0.37
▸ JAK2 O60674 3/20 0.34
▸ PDE4D Q08499 2/20 0.34
▸ KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26523264 0.95 TYK2 (0.48) TYK2JAK1CYP2C19JAK2PDE4D
SCHEMBL24498025 0.87 TYK2 (0.45) TYK2JAK1JAK2PDE4DKCNH2
SCHEMBL29684943 0.87 TYK2 (0.45) TYK2JAK1JAK2PDE4DKCNH2
SCHEMBL29684716 0.86 TYK2 (0.47) TYK2JAK1JAK2PDE4DKCNH2
SCHEMBL24497693 0.86 TYK2 (0.47) TYK2JAK1JAK2PDE4DKCNH2
SCHEMBL29686634 0.85 TYK2 (0.42) TYK2JAK1CYP2C19
SCHEMBL24498302 0.84 TYK2 (0.51) TYK2JAK1CYP2C19JAK2PDE4D
SCHEMBL24498345 0.84 TYK2 (0.58) TYK2JAK1JAK2KCNH2
SCHEMBL24498499 0.83 TYK2 (0.50) TYK2JAK1CYP2C19JAK2PDE4D
SCHEMBL29686876 0.83 TYK2 (0.54) TYK2JAK1CYP2C19JAK2PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257587-A1 HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shenzhen Chipscreen Biosciences Co., Ltd. (CN) 2023-10-11 — — EP claimed
CN-116283954-A Hydroxamate compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2023-06-23 — — CN claimed
CN-114901656-A Hydroximic acid ester compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2022-08-12 — — CN claimed
US-20240101548-A1 HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD (CN) 2024-03-28 — — US disclosed
EP-4257587-A1 HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shenzhen Chipscreen Biosciences Co., Ltd. (CN) 2023-10-11 — — EP disclosed
CN-116283954-A Hydroxamate compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2023-06-23 — — CN disclosed
CN-114901656-B Hydroximic acid ester compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2023-04-07 — — CN disclosed
CN-114901656-A Hydroximic acid ester compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2022-08-12 — — CN disclosed
WO-2022117016-A1 HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 深圳微芯生物科技股份有限公司 2022-06-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240101548-A1 HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF TYK2, WEE2, WEE1 TYK2 1/4885JAK1 10/4885CYP2C19 3032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback